PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 37 |
| PubMedID- 24265250 | We investigated the relation between diabetic autonomic neuropathy (dan) and left ventricular (lv) function in 59 patients with type 2 diabetes mellitus (t2dm) free of coronary artery disease (cad) or hypertension. |
| PubMedID- 22276258 | Screening for coronary artery disease in patients with type 2 diabetes mellitus: an evidence-based review. |
| PubMedID- 24600114 | Background: the mortality and morbidity rates are two to fourfold higher among coronary artery disease (cad) patients with type 2 diabetes mellitus (dm). |
| PubMedID- 23609464 | Serum s100a12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24273550 | Decreased mirna-126 was also found in atherosclerotic coronary artery disease (cad) and in patients with type 2 diabetes mellitus and may reflect the condition of vascular endothelial cells in heart failure patients (fukushima et al., 2011). |
| PubMedID- 24282409 | Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. |
| PubMedID- 21846893 | Letter by santos et al regarding article, "pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease". |
| PubMedID- 26413550 | They reported that urinary albumin excretion rate was independently correlated with coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25931789 | The aim of this study was to evaluate the association of plasma fibroblast growth factor (fgf)-21 with angiographically significant coronary artery disease (cad) in patients with type 2 diabetes mellitus. |
| PubMedID- 26521236 | Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study. |
| PubMedID- 25438840 | Diagnostic power of longitudinal strain at rest for the detection of obstructive coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23042402 | [association between sumo4 polymorphisms and coronary artery disease with and without type 2 diabetes mellitus]. |
| PubMedID- 25042974 | [prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in primary care]. |
| PubMedID- 26268997 | Alterations in lipid transfers to hdl associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24029567 | The relation between systolic body mass index (bmi), hemoglobin (hb), serum uric acid (ua), total cholesterol(tc), triglyceride (tg), high density lipoprotein cholesterol (hdl-c), low density lipoprotein cholesterol (ldl-c), smoking history, essential hypertension, type 2 diabetes mellitus, familial history of early coronary artery disease with acute myocardial infarction and severity of coronary artery disease are observed.and observe the characteristics of hdl-c in the obesity group and the smoking group in young men based on body mass index and smoking history. |
| PubMedID- 24049616 | Background: chronic kidney disease (ckd) coexisting with type 2 diabetes mellitus (dm) leads to coronary artery disease. |
| PubMedID- 22048611 | The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25810811 | Coronary artery disease in type 2 diabetes mellitus: recent treatment strategies and future perspectives. |
| PubMedID- 26089875 | Predictive potential of twenty-two biochemical biomarkers for coronary artery disease in type 2 diabetes mellitus. |
| PubMedID- 22553938 | Su et al [26] studied glycaemic variability determined by a continuous 72-hours glucose monitoring system and the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24240785 | Relationship between coronary artery disease and retinopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 24295032 | Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease. |
| PubMedID- 23597770 | Patients with type 2 diabetes mellitus without evidence of coronary artery disease were recruited. |
| PubMedID- 24667131 | Reported the coronary angiography data suggesting that small chylomicron remnants were implicated in the progression of coronary artery diseases in patients with type 2 diabetes mellitus [26]. |
| PubMedID- 21521347 | The aim of this study is to evaluate the association of the g82s polymorphism with the severity of coronary artery disease (cad) in patients with or without type 2 diabetes mellitus (t2dm). |
| PubMedID- 26265234 | Investigation of mda-ldl (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25031198 | Introduction: newly diagnosed type 2 diabetes mellitus (t2dm) in patients with coronary artery disease (cad) more than doubles the risk of death compared with otherwise matched glucose tolerant patients. |
| PubMedID- 21349201 | The objective of this study was to assess the relationship between glycemic variability determined by a continuous glucose monitoring (cgm) system and the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23391668 | Coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm) is associated with increased immediate and long-term mortality compared with patients without t2dm. |
| PubMedID- 23153979 | This study determined the role of endothelial nitric oxide synthase (enos) glu298asp polymorphism and intergenotypic variation of plasma nitric oxide (no) levels in coronary artery disease (cad) patients with type 2 diabetes mellitus (dm). |
| PubMedID- 21883999 | Platelet function assessed by verifynow p2y12 in coronary artery disease patients with type 2 diabetes mellitus (modified from [30]). |
| PubMedID- 20347119 | Introduction: type 2 diabetes mellitus (dm) patients with coronary artery disease (cad) have elevated plasma oxidized-ldl (oxldl) levels and impaired neovascularization. |
| PubMedID- 21034455 | Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 23018602 | Objectives: this study aimed to compare the value of serum glycated albumin (ga) level versus glycated hemoglobin a(1c) (hba(1c)) for evaluating the presence and severity of coronary artery disease (cad) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21386092 | Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. |
| PubMedID- 25964115 | Association of elevated apoa-i glycation and reduced hdl-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus. |
| PubMedID- 22081334 | The objective of this work was to determine the role of tnfalpha-308g/a gene polymorphism in metabolic syndrome (mets) and coronary artery disease (cad) with obesity and type 2 diabetes mellitus (t2dm). |
Page: 1